Silk Road Medical (SILK)
(Delayed Data from NSDQ)
$27.09 USD
+0.03 (0.11%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $27.08 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Balance Sheet
Fiscal Year End for Silk Road Medical, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 181 | 214 | 110 | 147 | 91 |
Receivables | 24 | 18 | 12 | 9 | 9 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 30 | 19 | 18 | 10 | 10 |
Other Current Assets | 6 | 4 | 3 | 7 | 3 |
Total Current Assets | 241 | 255 | 143 | 173 | 112 |
Net Property & Equipment | 8 | 9 | 8 | 3 | 3 |
Investments & Advances | 9 | 0 | 0 | 0 | 18 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 7 | 5 | 6 | 3 | 4 |
Total Assets | 265 | 270 | 157 | 179 | 137 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 6 | 3 | 2 | 3 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 4 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 25 | 22 | 20 | 17 | 15 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 30 | 24 | 26 | 20 | 17 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 76 | 75 | 45 | 49 | 45 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 8 | 7 | 7 | 4 | 4 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 114 | 106 | 77 | 72 | 66 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 551 | 508 | 368 | 346 | 263 |
Retained Earnings | -399 | -344 | -289 | -239 | -192 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 151 | 164 | 79 | 108 | 72 |
Total Liabilities & Shareholder's Equity | 265 | 270 | 157 | 179 | 137 |
Total Common Equity | 151 | 164 | 79 | 108 | 72 |
Shares Outstanding | 38.90 | 38.10 | 34.90 | 33.90 | 30.80 |
Book Value Per Share | 3.89 | 4.30 | 2.27 | 3.17 | 2.33 |
Fiscal Year End for Silk Road Medical, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 174 | 181 | 193 | 188 |
Receivables | NA | 27 | 24 | 22 | 22 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 30 | 30 | 22 | 19 |
Other Current Assets | NA | 4 | 6 | 4 | 5 |
Total Current Assets | NA | 236 | 241 | 241 | 234 |
Net Property & Equipment | NA | 8 | 8 | 8 | 9 |
Investments & Advances | NA | 2 | 9 | 4 | 14 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 7 | 7 | 7 | 7 |
Total Assets | NA | 252 | 265 | 261 | 263 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 3 | 6 | 5 | 5 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 18 | 25 | 19 | 19 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 21 | 30 | 24 | 24 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 76 | 76 | 75 | 75 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 8 | 8 | 9 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 105 | 114 | 108 | 108 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 561 | 551 | 540 | 529 |
Retained Earnings | NA | -414 | -399 | -386 | -374 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 147 | 151 | 153 | 156 |
Total Liabilities & Shareholder's Equity | NA | 252 | 265 | 261 | 263 |
Total Common Equity | 0 | 147 | 151 | 153 | 156 |
Shares Outstanding | 39.40 | 39.40 | 38.90 | 38.80 | 38.70 |
Book Value Per Share | 0.00 | 3.74 | 3.89 | 3.95 | 4.02 |